Review of Interventional Late Breaking Trials From AHA Scientific Sessions 2020 Virtual Meeting

Authors :: Brian C. Case
Giorgio A. Medranda
Jason P. Wermers
Chava Chezar-Azerrad
Brian J. Forrestal
Charan Yerasi
Natalie Morrison
Ron Waksman
Source :: Cardiovascular Revascularization Medicine
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: BMI, body mass index
UA, unstable angina
HT-DES, healing targeted Supreme DES
Cardiology
DHA, docosahexaenoic acid
Article
MINOCA, myocardial infarction with non-obstructive coronary artery disease
HDL-C, high-density lipoprotein cholesterol
TLR, target lesion revascularization
Humans
ID, ischemia-driven
Medicine
TV, target vessel
DES, drug-eluting stent
hsCRP, high-sensitivity C-reactive protein
NHANES, National Health and Nutrition Examination Survey
TLF, target lesion failure
COVID-19, coronavirus disease 2019
ACS, acute coronary syndromes
AHA, American Heart Association
CA, carboxylic acids
PCI, percutaneous coronary intervention
Medical education
CTCA, computed tomography coronary angiography
OCT, optical coherence tomography
business.industry
General Medicine
EPA, eicosapentaenoic acid
CMR, cardiac magnetic resonance imaging
HR, hazard ratio
CI, confidence interval
STEMI, ST-elevation myocardial infarction
CCS, chronic coronary syndromes
Cardiovascular Diseases
Research Design
DAPT, dual anti-platelet therapy
MACE, major adverse cardiovascular events
MI, myocardial infarction
LDL-C, low-density lipoprotein cholesterol
DP-DES, polymer based DES
Cardiology and Cardiovascular Medicine
business
Apo-B, apolipoprotein B
PCSK9, proprotein convertase subtilisin/kexin type 9

Tools